Although fusion of the AR regulated TMPRSS2 promoter to ETS related gene (ERG) that results in ERG overexpression [25, 26] is a common event in CA prostate cancer patients (50–70%), it is less frequent among AA and other ethnic groups [100–103]. The gene discussed is TMPRSS2; the disease is Familial prostate cancer.